# Internal Radioactive Contamination —Development of Decorporation Agents - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/internal-radioactive-contamination-development-of-decorporation-agents/2c9ecc52-8f94-400c-a1be-8bf28a25e1a8

> FDA guidance document: Internal Radioactive Contamination —Development of Decorporation Agents. Issue date: March 02, 2006. Get complete insights and analysis.

---

## Details

- Title: Internal Radioactive Contamination —Development of Decorporation Agents
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2006-03-02
- Last Changed: 2020-05-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0025">FDA-2005-D-0025</a>

## Related Documents

- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency](https://www.globalkeysolutions.net/guidances/guidance-document/antiviral-product-development-conducting-and-submitting-virology-studies-to-the-agency/81122360-623f-492b-84a2-d1ef7e31728f)
- [Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics](https://www.globalkeysolutions.net/guidances/guidance-document/prescription-drug-marketing-act-donation-of-prescription-drug-samples-to-free-clinics/703c91fa-8616-445a-8a1e-5ad08e94d3f4)